Hi Jerry - I guess Phase 1 went well with no adverse side affects and 3/4 of participants gained benefits . From Feb 2018- https://multiplesclerosisnewstoday.c...ell-treatment/
For Phase 11- The Phase 2 trial (NCT03355365) is recruiting about 50 patients with primary progressive or secondary progressive MS. Patients must have an EDSS between 3 and 6.5.
https://clinicaltrials.gov/ct2/show/...55365#contacts
Announcement
Collapse
No announcement yet.
What's happening with Dr. Sadiq's stem cell therapy ?
Collapse
X
Leave a comment: